Wearemikra

Wearemikra is a direct-to-consumer wellness brand that sells ingestible cellular-health supplements and powdered “super-cell” blends. The line-up centers on single-ingredient capsules (e.g., pure C15:0, astaxanthin, spermidine) and targeted stacks for skin, cognition, and longevity, priced USD $29-$79 per 30-day supply—solidly mid-range. Sales are online-only through wearemikra.com and Amazon; no retail distribution. The brand’s hook is “cell-first” nutrition: every SKU is built around peer-reviewed longevity compounds, third-party tested for ≥98 % purity, and delivered in lipid or cyclodextrin carriers that claim 3-5× higher cellular uptake. Flagship SKU “Cell-Therapy” combines C15:0, fisetin, and spermidin-R in one daily sachet and accounts for roughly half of recurring revenue. Core buyers are 25-45-year-old urban professionals who track HRV, follow Huberman-type podcasts, and want research-backed biohacks without prescription hoops. Sustainability and clean-label credentials (vegan capsules, carbon-neutral pouches) reinforce a “optimize today, age better tomorrow” value set. Mikra competes in the crowded longevity-supplement aisle against science-forward, DTC pill brands. It differentiates by limiting SKUs to molecules with human ORAC or senolytic data, publishing Certificates of Analysis on every batch page, and offering a 60-day “feel-it-or-free” guarantee—uncommon risk-reversal in the category.